Management of Heart Failure with Renal Artery Ischemia

Slides:



Advertisements
Similar presentations
KIDNEY & HYPERTENTION 1 Dr. Ruba Nashawati. Kidney Hypertension 2.
Advertisements

Atrial Fibrillation and Heart Failure Andrew A. Grace, MB, PhD, FRCP Heart Failure Clinics Volume 9, Issue 4, (October 2013) DOI: /j.hfc
Stage B, a Pre-cursor of Heart Failure Jay N. Cohn, MD, Gary S. Francis, MD Heart Failure Clinics Volume 8, Issue 1, Pages xvii-xviii (January 2012) DOI:
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Uncertain Value of Renal Artery Interventions:
Renovascular Disease Daniel Shoskes MD, MSc, FRCSC
Endovascular Treatment of Vertebral Artery Stenosis
Robert C. Stanton, MD  American Journal of Kidney Diseases 
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
C. Scott Norris, M. D. , John S. Pfeiffer, M. D. , Stanley E
Renal Artery Stenosis: When to Revascularize in 2017
THOMAS F. LÜSCHER, M.D.  Mayo Clinic Proceedings 
Copyright © 2015 by the American Osteopathic Association.
Patients with abdominal aortic aneurysm: Are we missing the opportunity for cardiovascular risk reduction?  G.M. Lloyd, MRCS, J.D. Newton, MRCP, M.G.A.
Animal Models and Physiologic Models And Physiologic Assessment
Follow-up of renal artery stenosis by duplex ultrasound
Cláudia Fagundes, MD, Pere Ginès, MD, PhD 
Never Too Late to Drink From the Fountain of Youth
Brian Radbill, MD, Barbara Murphy, MD, Derek LeRoith, MD, PhD 
Diagnosis and Management of Chronic Kidney Disease
Jeffrey W. Olin, DO, Brett A. Sealove, MD  Journal of Vascular Surgery 
William Insull, MD  The American Journal of Medicine 
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Stephen C. Textor, Sanjay Misra, Gustavo S. Oderich 
Peripheral Arterial Disease: Diagnosis and Management
Vahab Fatourechi, M. D. , Frank P. Kennedy, M. D. , Robert A. Rizza, M
Update on Diabetic Nephropathy: Core Curriculum 2018
Cardiovascular Disease and CKD: Core Curriculum 2010
Editorial Heart Failure Clinics
John P. Middleton, Patrick H. Pun  Kidney International 
Mark G. Davies, MD, PhD, MBA, Wael E. Saad, MD, Jean X
Peter A. McCullough, MD, MPH  Advances in Chronic Kidney Disease 
Volume 10, Issue 4, Pages ix-x (October 2014)
Stage B, a Pre-cursor of Heart Failure
Is There Any Reason to Stent Atherosclerotic Renal Artery Stenosis?
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Clinical Trials to “Real-World” Heart Failure: Applying Risk Stratification to Deliver Personalized Care  Ragavendra R. Baliga, MD, MBA  Heart Failure.
A New Era of Renal Denervation Trials for Patients With Hypertension?
Unilateral renal artery revascularization can salvage renal function and terminate dialysis in selected patients with uremia  Enrico Ascer, MD, Mark Gennaro,
Hypertension After Kidney Transplant
Renovascular hypertension in children
Pulmonary Hypertension
Atrial Fibrillation and Heart Failure
Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management  Uday M Khosla, MD, Richard J.
Volume 69, Issue 4, Pages (February 2006)
Update on Diabetic Nephropathy: Core Curriculum 2018
Follow-up of renal artery stenosis by duplex ultrasound
Severe Circadian Hypertension in a Young Man
Preface Heart Failure Clinics
George H. Meier, MD, Bauer Sumpio, MD, PhD, Henry R
Reversible Hyponatremia Related to Pericardial Tamponade
Atherosclerotic renovascular disease among hypertensive adults
Atrial Fibrillation and Heart Failure: It Takes Two to Tango
Charles S. O'Mara, MD, Michael D. Maples, MD, Thomas L
The occluded renal artery: Durability of revascularization
Volume 62, Issue 4, Pages (October 2002)
Cardiovascular risk factors in chronic kidney disease
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Editorial Heart Failure Clinics
Karen A. Griffin, Anil K. Bidani  Kidney International 
Aortoiliac surgery in renal transplant patients
Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience  Elaine Yutan, MD, David.
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Supportive care for patients with renal disease: Time for action
E. Rand Sutherland, MD, MPH  Journal of Allergy and Clinical Immunology 
Concomitant renal endarterectomy and aortic reconstruction
Carl E. Bredenberg, MD, Lawrence N. Sampson, MD, Ferris S. Ray, MD, R
Surgical correction of abdominal aortic coarctation and hypertension
Reversible Hyponatremia Related to Pericardial Tamponade
Arterial fibrodysplasia: Rapid progression complicated by rupture of a visceral aneurysm into the gastrointestinal tract  G. den Butter, M.D., J.H. van.
Richard L. McCann, MD, R.Randal Bollinger, MD, Glenn E. Newman, MD 
Presentation transcript:

Management of Heart Failure with Renal Artery Ischemia Madhav V. Rao, MD, Patrick Murray, MD, Clyde W. Yancy, MD  Heart Failure Clinics  Volume 4, Issue 4, Pages 465-478 (October 2008) DOI: 10.1016/j.hfc.2008.03.010 Copyright © 2008 Elsevier Inc. Terms and Conditions

Fig. 1 Interrelation among RAS, hypertension, and chronic renal failure. RAS may occur alone (isolated anatomic RAS) or in combination with hypertension (renovascular or essential hypertension), renal insufficiency (ischemic nephropathy), or both. Patients who have RAS alone may benefit from revascularization to prevent loss of renal mass. In patients who have RAS and hypertension, hypertension seldom is cured by revascularization, except in those who have FMD. In patients who have RAS and chronic renal failure, renal revascularization may improve or stabilize renal function. (From Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344[6]:431–42; with permission. Copyright © 2001, Massachusetts Medical Society.) Heart Failure Clinics 2008 4, 465-478DOI: (10.1016/j.hfc.2008.03.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Fig. 2 Progressive atherosclerosis, RAS, and ischemic nephropathy. In the early phase (A), there is mild atherosclerosis of the perirenal abdominal aorta and normal renal function. Renal blood flow, renal mass, and the serum creatinine concentration are normal. The dimensions of the kidneys are normal, and there is no cortical atrophy. The total GFR (100 mL per minute) and the GFR in each kidney (50 mL per minute) are normal. As the disease progresses (B), there is progressive aortic atherosclerosis and severe unilateral RAS. The left kidney is smaller than the right kidney, and there may be cortical thinning and asymmetry in renal blood flow. The serum creatinine concentration remains normal as long as the right kidney is normal, despite the loss of renal mass. The total GFR may be normal (100 mL per minute) or only slightly depressed owing to compensatory changes in the right kidney, but renal blood flow is decreased in the left kidney (35 mL per minute). In advanced disease (C), there is bulky atherosclerotic plaque in the perirenal aorta and severe bilateral RAS. Both kidneys are small, and there is marked cortical thinning and irregularity. Loss of more than 50% of renal mass usually is associated with an elevation in the serum creatinine concentration (ischemic nephropathy), which may not be reversible. The total GFR (30 mL per minute) and the GFR in each kidney (15 mL per minute) are depressed. (From Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344[6]:431–42; with permission. Copyright © 2001, Massachusetts Medical Society.) Heart Failure Clinics 2008 4, 465-478DOI: (10.1016/j.hfc.2008.03.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Fig. 3 Renal angiogram showing the typical string-of-beads appearance of FMD. (From Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull 2005;73–4:35–55; with permission.) Heart Failure Clinics 2008 4, 465-478DOI: (10.1016/j.hfc.2008.03.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Fig. 4 Two-kidney, one-clip model of renovascular hypertension. ATI, angiotensin I; AT1I, angiotensin II; JGA, juxtaglomerular apparatus. (From Rundback JH, Murphy TP, Cooper C, et al. Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease. J Vasc Interv Radiol 2002;13[11]:1085–92; with permission.) Heart Failure Clinics 2008 4, 465-478DOI: (10.1016/j.hfc.2008.03.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Fig. 5 Two-kidney, two-clip model of renovascular hypertension. AT, angiotensin; JGA, juxtaglomerular apparatus. (From Rundback JH, Murphy TP, Cooper C, et al. Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease. J Vasc Interv Radiol 2002;13(11):1085–92; with permission.) Heart Failure Clinics 2008 4, 465-478DOI: (10.1016/j.hfc.2008.03.010) Copyright © 2008 Elsevier Inc. Terms and Conditions